Nice to see your post Pcka! Do you think the news is already baked into the price or there is more room to run? It is interesting that this drug has been approved just when another major JNJ (and Amgen) drug EPO goes off patent.
Don't think so. It rallied because the category was in a bull move. The "possibility" of the approval was known possibility with conditions. However the decision was an all clear. That is bullish. Enjoy the ride to 90s.